Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Jan-23 5:48 PM View:  | Antigenics Inc. (AGEN) | 05-Jan-23 | Grant | 31,294 | $2.45 | $76,670.30 | 26% 122.64K to 153.94K | |
| 04-Feb-22 5:50 PM View: | Antigenics Inc. (AGEN) | 02-Feb-22 | Grant | 29,587 | $2.51 | $74,263.40 | 32% 93.06K to 122.64K | |
| 14-Sep-21 5:30 PM View: | Antigenics Inc. (AGEN) | 10-Sep-21 | Option Exercise | 16,563 | $3.36 | $55,651.70 | 19% 87.61K to 104.18K | |
| 14-Sep-21 5:30 PM View: | Antigenics Inc. (AGEN) | 10-Sep-21 | Market Option Sale | 11,120 | $6.50 | $72,280.00 | (11%) 104.18K to 93.06K | |
| 05-Apr-21 9:01 AM View: | Antigenics Inc. (AGEN) | 02-Apr-21 | Grant | 24,278 | $2.87 | $69,677.90 | 38% 64.33K to 88.61K | 0% |
| 14-Dec-17 4:21 PM View: | Antigenics Inc. (AGEN) | 12-Dec-17 | Market Sale | 5,610 | $3.46 | $19,417.90 | (8%) 69.94K to 64.33K | (6%) |
| 14-Dec-17 4:21 PM View: | Antigenics Inc. (AGEN) | 09-Oct-17 | Grant | 10,431 | $3.59 | $37,447.30 | 18% 59.51K to 69.94K | |
| 25-May-17 9:52 PM View: | American DG Energy, Inc. (ADGE) | 23-May-17 | Disposition (other) | 1,000 | -- | -- | (100%) 1.0K to 0 | |
| 21-Apr-17 4:29 PM View: | Antigenics Inc. (AGEN) | 19-Apr-17 | Grant | 10,429 | $3.39 | $35,354.30 | 20% 52.82K to 63.24K | 8% |
| 21-Apr-17 4:29 PM View: | Antigenics Inc. (AGEN) | 19-Apr-17 | Disposition | 3,733 | $3.39 | $12,654.90 | (6%) 63.24K to 59.51K | (8%) |
| 28-Apr-16 4:22 PM View: | Antigenics Inc. (AGEN) | 26-Apr-16 | Grant | 10,325 | $4.15 | $42,848.80 | 100% 0 to 10.32K | (12%) |
| 28-Apr-16 4:22 PM View: | Antigenics Inc. (AGEN) | 26-Apr-16 | Disposition | 3,517 | $4.15 | $14,595.60 | (34%) 10.32K to 6.81K | 12% |
| 24-Nov-14 1:11 PM View: | American DG Energy, Inc. (ADGE) | 21-Nov-14 | Market Purchase | 1,000 | $0.72 | $715.20 | 100% 0 to 1.0K | (55%) |
| 29-Jan-13 10:15 AM View: | Antigenics Inc. (AGEN) | 28-Jan-13 | Grant | 417 | $4.35 | $1,813.95 | 2% 23.27K to 23.69K | (16%) |
| 29-Oct-12 4:29 PM View: | Antigenics Inc. (AGEN) | 26-Oct-12 | Grant | 417 | $4.42 | $1,843.14 | 2% 22.86K to 23.27K | (17%) |
| 14-Sep-12 3:39 PM View: | Antigenics Inc. (AGEN) | 12-Sep-12 | Grant | 1,660 | -- | -- | 8% 21.2K to 22.86K | |
| 30-Jul-12 2:02 PM View: | Antigenics Inc. (AGEN) | 26-Jul-12 | Grant | 416 | $4.61 | $1,917.76 | 2% 20.78K to 21.2K | (21%) |
| 21-Jun-12 4:43 PM View: | Antigenics Inc. (AGEN) | 21-Jun-12 | Disposition | 3,810 | $5.05 | $19,240.50 | (15%) 24.59K to 20.78K | 28% |
| 21-Jun-12 4:43 PM View: | Antigenics Inc. (AGEN) | 20-Jun-12 | Disposition | 3,646 | $4.99 | $18,193.50 | (13%) 28.24K to 24.59K | 27% |
| 21-Jun-12 4:43 PM View: | Antigenics Inc. (AGEN) | 19-Jun-12 | Grant | 20,780 | $5.26 | $109,303.00 | 279% 7.46K to 28.24K | (30%) |
| 30-Apr-12 1:57 PM View: | Antigenics Inc. (AGEN) | 26-Apr-12 | Grant | 417 | $6.43 | $2,681.31 | 2% 20.36K to 20.78K | (43%) |
| 16-Mar-12 2:17 PM View: | Antigenics Inc. (AGEN) | 15-Mar-12 | Grant | 2,000 | $5.31 | $10,620.00 | 11% 18.36K to 20.36K | (31%) |
| 31-Jan-12 8:43 AM View: | Antigenics Inc. (AGEN) | 26-Jan-12 | Grant | 417 | $2.76 | $1,150.92 | 2% 17.95K to 18.36K | 33% |
| 05-Jan-12 2:48 PM View: | Antigenics Inc. (AGEN) | 03-Jan-12 | Grant | 12,789 | $2.17 | $27,752.10 | 248% 5.16K to 17.95K | 69% |
| 29-Dec-11 4:04 PM View: | Antigenics Inc. (AGEN) | 29-Dec-11 | Market Sale | 6,391 | $2.00 | $12,782.00 | (518%) (-1.23K) to 5.16K | 83% |
| 29-Dec-11 4:04 PM View: | Antigenics Inc. (AGEN) | 28-Dec-11 | Market Sale | 1,095 | $2.09 | $2,288.55 | 10% 10.45K to 11.55K | 75% |
| 29-Dec-11 4:04 PM View: | Antigenics Inc. (AGEN) | 27-Dec-11 | Market Sale | 1,824 | $2.14 | $3,903.36 | (13%) 14.47K to 12.64K | (71%) |
| 23-Dec-11 5:02 PM View: | Antigenics Inc. (AGEN) | 23-Dec-11 | Market Sale | 511 | $2.20 | $1,122.82 | (3%) 14.98K to 14.47K | (67%) |
| 23-Dec-11 5:02 PM View: | Antigenics Inc. (AGEN) | 22-Dec-11 | Market Sale | 993 | $2.19 | $2,174.97 | (6%) 15.97K to 14.98K | (67%) |
| 23-Dec-11 5:02 PM View: | Antigenics Inc. (AGEN) | 21-Dec-11 | Market Sale | 1,975 | $2.24 | $4,420.05 | (11%) 17.95K to 15.97K | (64%) |
| 28-Oct-11 10:53 AM View: | Antigenics Inc. (AGEN) | 26-Oct-11 | Grant | 416 | $2.70 | $1,123.20 | 2% 17.53K to 17.95K | 36% |
| 13-Sep-11 12:40 PM View: | Antigenics Inc. (AGEN) | 13-Sep-11 | Grant | 3,334 | $0.55 | $1,833.70 | 3% 101.86K to 105.19K | 11% |
| 28-Jul-11 11:53 AM View: | Antigenics Inc. (AGEN) | 26-Jul-11 | Grant | 2,500 | $0.79 | $1,975.00 | 3% 99.16K to 101.66K | (26%) |
| 28-Apr-11 12:13 PM View: | Antigenics Inc. (AGEN) | 26-Apr-11 | Grant | 2,500 | $0.92 | $2,300.00 | 3% 96.86K to 99.36K | (36%) |
| 11-Mar-11 9:49 AM View: | Antigenics Inc. (AGEN) | 09-Mar-11 | Grant | 6,000 | $0.98 | $5,880.00 | 7% 90.86K to 96.86K | (40%) |
| 28-Jan-11 10:20 AM View: | Antigenics Inc. (AGEN) | 26-Jan-11 | Grant | 2,500 | $0.95 | $2,375.00 | 3% 88.36K to 90.86K | (36%) |
| 20-Jan-11 4:49 PM View: | Antigenics Inc. (AGEN) | 20-Jan-11 | Grant | 16,705 | $0.94 | $15,702.70 | 23% 71.65K to 88.36K | (35%) |
| 28-Oct-10 2:44 PM View: | Antigenics Inc. (AGEN) | 26-Oct-10 | Grant | 2,500 | $0.98 | $2,450.00 | 3% 71.65K to 74.15K | (38%) |
| 28-Oct-10 2:44 PM View: | Antigenics Inc. (AGEN) | 26-Oct-10 | Market Sale (Planned) | 2,500 | $0.97 | $2,425.00 | (3%) 74.15K to 71.65K | 38% |
| 14-Sep-10 2:21 PM View: | Antigenics Inc. (AGEN) | 14-Sep-10 | Market Sale (Planned) | 1,365 | $0.91 | $1,238.87 | (2%) 73.02K to 71.65K | 35% |
| 14-Sep-10 2:21 PM View: | Antigenics Inc. (AGEN) | 10-Sep-10 | Grant | 3,333 | $0.93 | $3,099.69 | 5% 69.68K to 73.02K | (37%) |
| 28-Jul-10 11:31 AM View: | Antigenics Inc. (AGEN) | 26-Jul-10 | Grant | 2,500 | $0.79 | $1,975.00 | 4% 69.68K to 72.18K | (26%) |
| 28-Jul-10 11:31 AM View: | Antigenics Inc. (AGEN) | 26-Jul-10 | Market Sale (Planned) | 2,500 | $0.80 | $2,000.00 | (3%) 72.18K to 69.68K | 27% |
| 28-Apr-10 2:07 PM View: | Antigenics Inc. (AGEN) | 26-Apr-10 | Grant | 2,500 | $1.19 | $2,975.00 | 4% 69.68K to 72.18K | (50%) |
| 28-Apr-10 2:07 PM View: | Antigenics Inc. (AGEN) | 26-Apr-10 | Market Sale (Planned) | 2,500 | $1.21 | $3,033.00 | (3%) 72.18K to 69.68K | 51% |
| 21-Jan-10 11:17 AM View: | Antigenics Inc. (AGEN) | 20-Jan-10 | Market Sale (Planned) | 78,868 | $0.85 | $67,306.00 | (859%) (-9.19K) to 69.68K | (30%) |
| 21-Jan-10 11:17 AM View: | Antigenics Inc. (AGEN) | 19-Jan-10 | Grant | 78,868 | $0.90 | $70,981.20 | 113% 69.68K to 148.55K | (34%) |
| 14-Sep-09 9:19 AM View: | Antigenics Inc. (AGEN) | 11-Sep-09 | Market Sale | 1,325 | $2.32 | $3,077.97 | (2%) 71.01K to 69.68K | 75% |
| 14-Sep-09 9:19 AM View: | Antigenics Inc. (AGEN) | 10-Sep-09 | Grant | 3,333 | $2.40 | $7,999.20 | 5% 67.67K to 71.01K | (76%) |
| 17-Jul-09 3:09 PM View: | Antigenics Inc. (AGEN) | 16-Jul-09 | Market Sale | 19,905 | $1.62 | $32,206.30 | (23%) 87.58K to 67.67K | 73% |